126 related articles for article (PubMed ID: 12532373)
1. Subtleties in crystal structure solution from powder diffraction data using simulated annealing: ranitidine hydrochloride.
Huq A; Stephens PW
J Pharm Sci; 2003 Feb; 92(2):244-9. PubMed ID: 12532373
[TBL] [Abstract][Full Text] [Related]
2. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine hydrochloride, a polymorphic crystal form.
Hempel A; Camerman N; Mastropaolo D; Camerman A
Acta Crystallogr C; 2000 Aug; 56 ( Pt 8)():1048-9. PubMed ID: 10944325
[TBL] [Abstract][Full Text] [Related]
4. Solid state characterization and crystal structure from X-ray powder diffraction of two polymorphic forms of ranitidine base.
de Armas HN; Peeters OM; Blaton N; Van Gyseghem E; Martens J; Van Haele G; Van Den Mooter G
J Pharm Sci; 2009 Jan; 98(1):146-58. PubMed ID: 18393299
[TBL] [Abstract][Full Text] [Related]
5. Structure determination from conventional powder diffraction data: application to hydrates, hydrochloride salts, and metastable polymorphs.
Stephenson GA
J Pharm Sci; 2000 Jul; 89(7):958-66. PubMed ID: 10861598
[TBL] [Abstract][Full Text] [Related]
6. Powder diffraction crystallography of molecular solids.
Harris KD
Top Curr Chem; 2012; 315():133-77. PubMed ID: 21952843
[TBL] [Abstract][Full Text] [Related]
7. Solving molecular crystal structures from X-ray powder diffraction data: the challenges posed by gamma-carbamazepine and chlorothiazide N,N,-dimethylformamide (1/2) solvate.
Fernandes P; Shankland K; Florence AJ; Shankland N; Johnston A
J Pharm Sci; 2007 May; 96(5):1192-202. PubMed ID: 17455337
[TBL] [Abstract][Full Text] [Related]
8. Mg(1 + x)Ir(1 - x) (x = 0, 0.037 and 0.054), a binary intermetallic compound with a new orthorhombic structure type determined from powder and single-crystal X-ray diffraction.
Cerný R; Renaudin G; Favre-Nicolin V; Hlukhyy V; Pöttgen R
Acta Crystallogr B; 2004 Jun; 60(Pt 3):272-81. PubMed ID: 15148430
[TBL] [Abstract][Full Text] [Related]
9. [Visible spectrophotometric assay of ranitidine].
Apostu M; Dorneanu V; Bibire N
Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):214-7. PubMed ID: 14756000
[TBL] [Abstract][Full Text] [Related]
10. The impact of powder diffraction on the structural characterization of organic crystalline materials.
Tremayne M
Philos Trans A Math Phys Eng Sci; 2004 Dec; 362(1825):2691-707. PubMed ID: 15539365
[TBL] [Abstract][Full Text] [Related]
11. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficiency of direct-space structure solution from powder X-ray diffraction data in the case of conformationally flexible molecules.
Hanson AJ; Cheung EY; Harris KD
J Phys Chem B; 2007 Jun; 111(23):6349-56. PubMed ID: 17516675
[TBL] [Abstract][Full Text] [Related]
13. Application of vibrational spectroscopy, thermal analyses and X-ray diffraction in the rapid evaluation of the stability in solid-state of ranitidine, famotidine and cimetidine.
Jamrógiewicz M; Ciesielski A
J Pharm Biomed Anal; 2015 Mar; 107():236-43. PubMed ID: 25625474
[TBL] [Abstract][Full Text] [Related]
14. Second SH3 domain of ponsin solved from powder diffraction.
Margiolaki I; Wright JP; Wilmanns M; Fitch AN; Pinotsis N
J Am Chem Soc; 2007 Sep; 129(38):11865-71. PubMed ID: 17784760
[TBL] [Abstract][Full Text] [Related]
15. The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.
Brüning J; Schmidt MU
J Pharm Pharmacol; 2015 Jun; 67(6):773-81. PubMed ID: 25677117
[TBL] [Abstract][Full Text] [Related]
16. Quantification of ranitidine hydrochloride in the presence of its decomposition product by spectrophotometric methods. Application for kinetic study.
Sokół A; Karpińska J; Talecka R; Starczewska B
Acta Pol Pharm; 2011; 68(2):169-77. PubMed ID: 21485289
[TBL] [Abstract][Full Text] [Related]
17. Detection of some volatile degradation products released during photoexposition of ranitidine in a solid state.
Jamrógiewicz M; Wielgomas B
J Pharm Biomed Anal; 2013 Mar; 76():177-82. PubMed ID: 23333686
[TBL] [Abstract][Full Text] [Related]
18. In vitro availability of metformin in presence of h(2) receptor antagonists.
Sultana N; Arayne MS; Ahmed N
Pak J Pharm Sci; 2006 Jan; 19(1):28-34. PubMed ID: 16632449
[TBL] [Abstract][Full Text] [Related]
19. Stability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injection.
Nolan PE; Hoyer GL; LeDoux JH; Fox JL
Am J Health Syst Pharm; 1997 Jun; 54(11):1304-6. PubMed ID: 9179353
[No Abstract] [Full Text] [Related]
20. Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
Giraldo J; Martín M; Campillo M; Pardo L
Mol Pharmacol; 1992 Aug; 42(2):373-81. PubMed ID: 1355265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
